123 related articles for article (PubMed ID: 15569847)
1. Sphingolipids and atherosclerosis: a mechanistic connection? A therapeutic opportunity?
Tabas I
Circulation; 2004 Nov; 110(22):3400-1. PubMed ID: 15569847
[No Abstract] [Full Text] [Related]
2. Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice.
Park TS; Panek RL; Mueller SB; Hanselman JC; Rosebury WS; Robertson AW; Kindt EK; Homan R; Karathanasis SK; Rekhter MD
Circulation; 2004 Nov; 110(22):3465-71. PubMed ID: 15545514
[TBL] [Abstract][Full Text] [Related]
3. Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice.
Park TS; Rosebury W; Kindt EK; Kowala MC; Panek RL
Pharmacol Res; 2008 Jul; 58(1):45-51. PubMed ID: 18611440
[TBL] [Abstract][Full Text] [Related]
4. Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment.
Johnson J; Carson K; Williams H; Karanam S; Newby A; Angelini G; George S; Jackson C
Circulation; 2005 Mar; 111(11):1422-30. PubMed ID: 15781753
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration.
Glaros EN; Kim WS; Wu BJ; Suarna C; Quinn CM; Rye KA; Stocker R; Jessup W; Garner B
Biochem Pharmacol; 2007 May; 73(9):1340-6. PubMed ID: 17239824
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E and atherosclerosis: beyond lipid effect.
Davignon J
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):267-9. PubMed ID: 15681305
[No Abstract] [Full Text] [Related]
7. Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice.
Hojjati MR; Li Z; Zhou H; Tang S; Huan C; Ooi E; Lu S; Jiang XC
J Biol Chem; 2005 Mar; 280(11):10284-9. PubMed ID: 15590644
[TBL] [Abstract][Full Text] [Related]
8. Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice.
Mercer J; Figg N; Stoneman V; Braganza D; Bennett MR
Circ Res; 2005 Apr; 96(6):667-74. PubMed ID: 15746445
[TBL] [Abstract][Full Text] [Related]
9. Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin.
Miyake Y; Kozutsumi Y; Nakamura S; Fujita T; Kawasaki T
Biochem Biophys Res Commun; 1995 Jun; 211(2):396-403. PubMed ID: 7794249
[TBL] [Abstract][Full Text] [Related]
10. Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress.
Meir KS; Leitersdorf E
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1006-14. PubMed ID: 15087308
[TBL] [Abstract][Full Text] [Related]
11. Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis.
Merched AJ; Chan L
Circulation; 2004 Dec; 110(25):3830-41. PubMed ID: 15596565
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
Nachtigal P; Pospisilova N; Jamborova G; Pospechova K; Solichova D; Andrys C; Zdansky P; Micuda S; Semecky V
Life Sci; 2008 Mar; 82(13-14):708-17. PubMed ID: 18289605
[TBL] [Abstract][Full Text] [Related]
13. Varying the ratio of dietary n-6/n-3 polyunsaturated fatty acid alters the tendency to thrombosis and progress of atherosclerosis in apoE-/- LDLR-/- double knockout mouse.
Yamashita T; Oda E; Sano T; Yamashita T; Ijiru Y; Giddings JC; Yamamoto J
Thromb Res; 2005; 116(5):393-401. PubMed ID: 16122552
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of probucol in two animal models of atherosclerosis.
Lau AK; Witting PK; Chaufour X; Celermajer DS; Pettersson K; Stocker R
Redox Rep; 2000; 5(2-3):116-8. PubMed ID: 10939287
[No Abstract] [Full Text] [Related]
15. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
Kitayama K; Nishizawa T; Abe K; Wakabayashi K; Oda T; Inaba T; Amemiya Y
J Pharm Pharmacol; 2006 Dec; 58(12):1629-38. PubMed ID: 17331327
[TBL] [Abstract][Full Text] [Related]
16. Sphingolipids and cardiovascular diseases: lipoprotein metabolism, atherosclerosis and cardiomyopathy.
Jiang XC; Goldberg IJ; Park TS
Adv Exp Med Biol; 2011; 721():19-39. PubMed ID: 21910080
[TBL] [Abstract][Full Text] [Related]
17. Combination of dietary phytosterols plus niacin or fenofibrate: effects on lipid profile and atherosclerosis in apo E-KO mice.
Yeganeh B; Moshtaghi-Kashanian GR; Declercq V; Moghadasian MH
J Nutr Biochem; 2005 Apr; 16(4):222-8. PubMed ID: 15808326
[TBL] [Abstract][Full Text] [Related]
18. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130
[TBL] [Abstract][Full Text] [Related]
19. Do atherosclerosis and chronic bladder ischemia really play a role in detrusor dysfunction of old age?
Shenfeld OZ; Meir KS; Yutkin V; Gofrit ON; Landau EH; Pode D
Urology; 2005 Jan; 65(1):181-4. PubMed ID: 15667900
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein receptors, macrophages, and sphingomyelinase.
Kraemer FB; Suzuki J
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2509-10. PubMed ID: 11116045
[No Abstract] [Full Text] [Related]
[Next] [New Search]
